Aspartic acid and epidermal growth factor modified decellularized rabbit conjunctiva for conjunctival reconstruction
Source abstract
Abstract
Conjunctival reconstruction is an indispensable part of ocular surface regeneration. Decellularized matrix has been considered as an ideal conjunctival substitution for conjunctival reconstruction. In the present study, we report the use of a decellularized rabbit conjunctiva (DRC) for conjunctival reconstruction in the rabbit surgical trauma model. Prepared by the phospholipase A2 decellularized method, the DRC was nearly DNA free while the collagen structure and natural extracellular matrix (ECM) were well preserved. In order to improve the performance of DRC, aspartic acid (Asp) was used as a spacer arm to crosslink epidermal growth factor (EGF) on the DRC to obtain DRC-Asp-EGF. The conjunctival epithelial cells cultured on the DRC-Asp-EGF showed a higher survival rates and a greater potential to differentiate into conjunctival goblet cells (CGCs) than those on the DRC. Finally, three groups were set to evaluate the transplantation effects in the rabbit surgical trauma model for 28 days: DRC-Asp-EGF group, amniotic membrane (AM) group, and ungrafted group. The DRC-Asp-EGF group was completely re-epithelized, and more CGCs were regenerated than the AM group, while no significant improvements were observed in the ungrafted group. Intact collagen structure, angiogenesis, and no scar formation were also observed in the DRC-Asp-EGF group. These results suggest that DRC-Asp-EGF is a feasible and effective transplant for conjunctival reconstruction and ocular surface regeneration.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Corneal Surgery and Treatments · Ocular Surface and Contact Lens · Ocular Disorders and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (49)
Show source-provided references
1. Ocular surface concepts: development and citation10.1016/j.jtos.2013.10.004 ↗
2. Conjunctival regeneration
3. Ocular epithelial transplantation: current uses and future potential10.2217/rme.11.94 ↗
4. Tissue engineering: current and future approaches to ocular surface reconstruction10.1016/S1542-0124(12)70039-3 ↗
5. A review of ocular graft-versus-host disease10.1097/OPX.0000000000001071 ↗
6. New approaches to ocular surface reconstruction beyond the cornea10.1007/s00347-016-0419-1 ↗
7. Amniotic membrane transplantation ineffective as additional therapy in patients with aggressive Mooren's ulcer10.1186/1471-2415-13-81 ↗
8. Amniotic membrane transplantation in ophthalmology: an updated perspective10.2147/OPTH.S208008 ↗
9. Extracellular matrix: a dynamic microenvironment for stem cell niche10.1016/j.bbagen.2014.01.010 ↗
10. 3D-Printed membrane as an alternative to amniotic membrane for ocular surface/conjunctival defect reconstruction: an in vitro & in vivo study10.1016/j.biomaterials.2018.05.013 ↗
11. A tarsus construct of a novel branched polyethylene with good elasticity for eyelid reconstruction in vivo10.1093/rb/rbaa001 ↗
12. In vivo conjunctival reconstruction using modified PLGA grafts for decreased scar formation and contraction10.1016/S0142-9612(03)00411-3 ↗
13. ECM and ECM-like materials - biomaterials for applications in regenerative medicine and cancer therapy10.1016/j.addr.2015.11.019 ↗
14. Decellularised conjunctiva for ocular surface reconstruction10.1016/j.actbio.2017.11.054 ↗
15. Development of decellularized conjunctiva as a substrate for the ex vivo expansion of conjunctival epithelium10.1002/term.2419 ↗
16. Conjunctiva reconstruction by induced differentiation of human amniotic epithelial cells10.4238/2015.October.29.2 ↗
17. Human amniotic membrane transplantation: different modalities of its use in ophthalmology10.5500/wjt.v4.i2.111 ↗
18. Urea-de-epithelialized human amniotic membrane for ocular surface reconstruction10.1002/sctm.18-0201 ↗
19. The application of an acellular dermal allograft (AlloDerm) for patients with insufficient conjunctiva during evisceration and implantation surgery10.1038/eye.2017.161 ↗
20. Conjunctival structural and functional reconstruction using acellular bovine pericardium graft (Normal GEN (R)) in rabbits10.1007/s00417-015-3201-1 ↗
21. The extracellular matrix: structure, composition, age-related differences, tools for analysis and applications for tissue engineering10.1177/2041731414557112 ↗
22. Preparation of high bioactivity multilayered bone-marrow mesenchymal stem cell sheets for myocardial infarction using a 3D-dynamic system10.1016/j.actbio.2018.03.052 ↗
23. Carbodiimide cross-linking of amniotic membranes in the presence of amino acid bridges10.1016/j.msec.2015.02.021 ↗
24. Stabilization of collagen with EDC/NHS in the presence of L-lysine: a comprehensive study10.1016/j.colsurfb.2011.10.002 ↗
25. Reactive oxygen species (ROS) are essential mediators in epidermal growth factor (EGF)-stimulated corneal epithelial cell proliferation, adhesion, migration, and wound healing10.1016/j.exer.2009.07.012 ↗
26. Autologous serum and plasma rich in growth factors in ophthalmology: preclinical and clinical studies10.1111/aos.12710 ↗
27. The use of phospholipase A(2) to prepare acellular porcine corneal stroma as a tissue engineering scaffold10.1016/j.biomaterials.2009.03.003 ↗
28. The conjunctival extracellular matrix, related disorders and development of substrates for conjunctival restoration
29. The extracellular matrix as a scaffold for tissue reconstruction10.1016/S1084952102000940 ↗
30. Structure and function of basement membranes10.3181/0703-MR-72 ↗
31. Biomaterials and controlled release strategy for epithelial wound healing10.1039/C9BM00456D ↗
32. Role of growth factors and biomaterials in wound healing10.1080/21691401.2018.1439836 ↗
33. Enhanced physicochemical properties of collagen by using EDC/NHS-crosslinking10.1007/s12034-012-0376-5 ↗
34. Tissue Engineering for conjunctival reconstruction: established methods and future outlooks10.3109/02713680903198045 ↗
35. The spectrum of cytokeratins expressed in the adult human cornea, limbus and perilimbal conjunctiva
36. Epidermal growth factor tethered to beta-tricalcium phosphate bone scaffolds via a high-affinity binding peptide enhances survival of human mesenchymal stem cells/multipotent stromal cells in an immune-competent parafascial implantation assay in mice10.5966/sctm.2015-0326 ↗
37. Surface tethered epidermal growth factor protects proliferating and differentiating multipotential stromal cells from FasL-induced apoptosis10.1002/stem.1215 ↗
38. Epidermal growth factor stimulates transforming growth factor-beta receptor type II expression in corneal epithelial cells10.1038/s41598-019-42969-2 ↗
39. Goblet cells of the conjunctiva: a review of recent findings10.1016/j.preteyeres.2016.04.005 ↗
40. Ocular surface repair using decellularized porcine conjunctiva10.1016/j.actbio.2019.11.006 ↗
41. SPDEF is required for mouse pulmonary goblet cell differentiation and regulates a network of genes associated with mucus production
42. Vascular endothelial growth factor and angiogenesis10.1124/pr.56.4.3 ↗
43. EGFR enhances early healing after cutaneous incisional wounding10.1111/j.0022-202X.2004.23478.x ↗
44. Extracellular regulation of TGF-beta activity in wound repair: growth factor latency as a sensor mechanism for injury
45. TGF-beta1 induces mouse dendritic cells to express VEGF and its receptor (Flt-1) under hypoxic conditions10.3858/emm.2010.42.9.059 ↗
46. Vascular endothelial growth factor: basic science and clinical progress10.1210/er.2003-0027 ↗
47. Applications of human amniotic membrane for tissue engineering
48. Eye socket regeneration and reconstruction10.1080/02713683.2020.1712423 ↗
49. Upregulation of distinct collagen transcripts in post-surgery scar tissue: a study of conjunctival fibrosis